A move that may result in reducing the price upto 50% of medical devices

India’s Prime Minister Narendra Modi, after declaring their plan to increase coal and gas production in the country, also said that their government now aims to increase medical devices manufacturing to boost the flagship scheme of ‘Make in India’. Government is planning to lead medical devices manufacturing market to $50 billion by 2025 from a current market size of nearly $11 billion.

Minister of MSME, Nitin Gadkar also said that his department has already planned to set up five parks to manufacture low-cost medical devices in the country. He also added a project that is being carried out under the Defence Research and Development Organisation (DRDO), to manufacture ‘Cochlear implant’ equipment.

750–800 domestic medical device manufacturers units are working in India, that form around 65% of such manufacturers and with the current move, the government aims to bring more FDI in India. However, the decision still has roadblocks ahead.

Medical devices such as syringes and others that do not need electronic equipment are increasingly made in India but those requiring electronic equipment are preferably being imported. Along with the low scale of production that is making the Indian medical device industry less competitive, there are other major hurdles lying ahead as well. “The government’s move will help only if it reaches the ground level. For instance, officials from the regulatory body are still seen as a threat and not as somebody who can help. So, the government will have to ensure trust and assure that the traders no more see the regulators as a threat,” Nikhilesh Tiwari, Founder, ColMed, told Financial Express Online. The government (including and especially state governments) and regulators should also take up the role of nurturing this industry and we should look forward to creating global leaders in this industry, he added.

In the last financial year, medical devices registered under the category “ Optical, photographic, cinematographic measuring, checking precision, medical or surgical instruments and apparatus parts and accessories thereof” saw around 20 per cent rise in growth, according to the Department of Commerce. 

Meanwhile, to give a fillip to the medical device sector, Suresh Prabhu, Minister of Commerce and Industry and Civil Aviation, last month announced setting up of a National Medical Devices Promotion Council under the Department of Industrial Policy and Promotion (DIPP). With this move, the government aimed to identify redundant processes and provide technical assistance to the concerned bodies to simplify the approval processes involved in medical device industry promotion and development.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre